behold.ai

Behold.ai has developed innovative AI-driven solutions to enhance cancer diagnostics through radiology:
red dot® Lung Cancer Detection Platform: This platform utilizes artificial intelligence to analyze chest X-rays (CXRs) and rapidly identify suspected lung cancer cases. By prioritizing these cases for immediate reporting, it significantly reduces the time to diagnosis, enabling faster intervention and treatment.
red dot® CTH V1: Designed for head CT scans, this AI solution autonomously identifies normal exams and triages acute findings around the clock. It aids in the swift detection of critical conditions, ensuring timely medical responses.
These solutions have demonstrated substantial benefits in clinical settings. For instance, at Calderdale and Huddersfield NHS Foundation Trust, the implementation of the red dot® service reduced the chest X-ray reporting backlog from seven days to just seven seconds, expediting patient care and optimizing radiology department efficiency.
However, as of January 2025, Behold.ai has entered administration after failing to secure contracts under the government’s AI Diagnostic Fund. This development has raised concerns about the future availability and support for their AI-driven diagnostic tools.
These advancements underscore Behold.ai’s commitment to leveraging artificial intelligence to improve the accuracy and efficiency of cancer diagnostics in radiology.